Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Xeris Pharmaceuticals (XERS)
NASDAQ:XERS
RESEARCH TOOLSreports
Holding XERS?
Track your performance easily
Xeris Pharmaceuticals (XERS) Ownership Overview
8.38% Insiders
8.31% Mutual Funds
0.16% Other Institutional Investors
9.59% ETFs
73.57% Public Companies and Individual Investors
The ownership structure of Xeris Pharmaceuticals (XERS) stock is a mix of institutional, retail, and individual investors. Approximately 18.06% of the company’s stock is owned by Institutional Investors, 8.38% is owned by Insiders, and 73.57% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 13, 2024 | John Schmid Director | xxxxxxxxxxxxx | $10114 |
| Aug 12, 2024 | John Schmid Director | xxxxxxxxxxxxx | $10113 |
| May 10, 2024 | John Schmid Director | xxxxxxxxxxxxx | $10314 |
| Mar 14, 2024 | John Schmid Director | xxxxxxxxxxxxx | $9720 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $98704 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $152341 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,376,913 | Institution | 4.95% | 23,901,198 | |
| 6,540,757 | Institution | 4.39% | 21,192,053 | |
| 5,730,419 | Institution | 3.84% | 18,566,558 | |
| 3,821,494 | Insider | 2.56% | 12,381,641 | |
| 2,108,618 | Insider | 1.41% | 6,831,922 | |
| 1,604,452 | Insider | 1.08% | 5,198,424 | |
| 1,547,503 | Institution | 1.04% | 5,013,910 | |
| 1,524,979 | Institution | 1.02% | 4,940,932 | |
| 1,409,761 | Insider | 0.95% | 4,567,626 | |
| 1,352,794 | Insider | 0.91% | 4,383,053 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,540,757 | Institution | 4.39% | 21,192,053 | |
| 1,547,503 | Institution | 1.04% | 5,013,910 | |
| 1,524,979 | Institution | 1.02% | 4,940,932 | |
| 707,458 | Institution | 0.47% | 2,292,164 | |
| 689,764 | Institution | 0.46% | 2,234,835 | |
| 403,361 | Institution | 0.27% | 1,306,890 | |
| 244,436 | Institution | 0.16% | 791,973 | |
| 124,732 | Institution | 0.08% | 404,132 | |
| 102,020 | Institution | 0.07% | 330,545 | |
| 84,399 | Institution | 0.06% | 273,453 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,220,661 | Institution | 2.83% | 13,843,768 | |
| 3,729,082 | Institution | 2.50% | 12,082,226 | |
| 2,292,340 | Institution | 1.54% | 7,518,875 | |
| 1,281,034 | Institution | 0.86% | 4,150,550 | |
| 658,059 | Institution | 0.44% | 2,158,434 | |
| 325,515 | Institution | 0.22% | 1,054,669 | |
| 291,948 | Institution | 0.20% | 934,234 | |
| 237,495 | Institution | 0.16% | 769,484 | |
| 205,282 | Institution | 0.14% | 665,114 | |
| 130,314 | Institution | 0.09% | 427,430 |
FAQ
Who Owns Xeris Pharmaceuticals (XERS)?
According to the latest TipRanks data, approximately 0.16% of the company's stock is held by institutional investors, 8.38% is held by insiders, and 73.57% is held by retail investors.
What percentage of Xeris Pharmaceuticals (XERS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.16% of Xeris Pharmaceuticals (XERS) stock is held by institutional investors.
What percentage of Xeris Pharmaceuticals (XERS) stock is held by retail investors?
According to the latest TipRanks data, approximately 73.57% of Xeris Pharmaceuticals (XERS) stock is held by retail investors.
Who owns the most shares of Xeris Pharmaceuticals (XERS)?
Vanguard owns the most shares of Xeris Pharmaceuticals (XERS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.